Celmatix Obtains Series A Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4d55eb1e-0ce1-4075-9b91-331cd77f32c4&Preview=1 -
Date
2/27/2011 -
Company Name
Celmatix -
Mailing Address
7 Hubert Street New York, NY 10013 -
Company Description
Celmatix, Inc. is a New York City-based biotechnology company targeting the reproductive medicine sector with products designed to improve reproductive technologies and outcomes. Our lead product under development is FertilArrayTM, an in vitro genetic diagnostic for assessing female egg quality and genetic indicators of female infertility. -
Website
http://www.celmatix.com -
Transaction Type
Venture Equity -
Transaction Amount
Undisclosed -
Transaction Round
Series A -
Proceeds Purposes
Celmatix will use the Series A financing to continue Research and Development for their proposed egg quality diagnostic, FertilArray. -
M&A Terms
-
Venture Investor
Topspin Partners
